Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Summary 
Currently, Andrew C. von Eschenbach occupies the position of President for Samaritan Health Initiatives, Inc.

He is also on the board of 15 other companies.

In the past he held the position of Director-FDA Project at Manhattan Institute For Policy Research, Inc., Director-National Cancer Institute at National Institutes of Health, Commissioner at US Food & Drug Administration, Principal at The University of Texas at Austin and Chairman-Urology Department at The University of Texas M.D. Anderson Cancer Center.

Dr. Von Eschenbach received an undergraduate degree from St. Joseph's University and a doctorate from Georgetown University School of Medicine.


Current positions of Andrew C. von Eschenbach 
NameTitle Since
Bausch + Lomb Corporation
(Medical Equipment, Supplies & Distribution)
Independent Director -
Bausch Health Companies Inc.
(Pharmaceuticals)
Independent Director 2018
Celularity Inc.
(Biotechnology & Medical Research)
Independent Director 2021
Radius Health, Inc.
(Biotechnology & Medical Research)
Independent Director 2021
Samaritan Health Initiatives, Inc. President 2010
Bausch & Lomb, Inc. Independent Director -
Viamet Pharmaceuticals, Inc. Director 2011
Viamet Pharmaceuticals Corp. Independent Director 2011
Innocrin Pharmaceuticals Holdings LLC Director -
Banyan Biomarkers, Inc. Director -
Focused Ultrasound Foundation Director 2010
Reagan-udall Foundation Director 2018
National Comprehensive Cancer Network Foundation Director -
Innocrin Pharmaceuticals, Inc. Director -
Wren Therapeutics Ltd. Director 2019
Celularity, Inc. (United States) Director 2018


Holdings of Andrew C. von Eschenbach 
NameEquities%Valuation
Celularity Inc. (CELU)
(Biotechnology & Medical Research)
100,0000.073%1,169,000 USD
Bausch + Lomb Corporation (BLCO)
(Medical Equipment, Supplies & Distribution)
12,5000.0036%245,000 USD
Bausch Health Companies Inc. (BHC)
(Pharmaceuticals)
8,5000.0024%161,585 USD
Radius Health, Inc. (RDUS)
(Biotechnology & Medical Research)
5,5000.012%37,620 USD


Andrew C. von Eschenbach: Personal Network 
Most Read News 
05/11CATHIE WOOD : Tumble in Coinbase pushes Wood's ARK fund closer to pandemic low
RE
05/12MASAYOSHI SON : SoftBank Vision Fund posts $26 billion loss; Son pledges defence
RE
05/20XAVIER NIEL : UWR shares spike as billionaire Xavier Niel discloses 27% stake
RE
05/14ELON MUSK : Elon Musk says Twitter legal team told him he violated an NDA
RE
05/11ELON MUSK : Musk's delay in disclosing Twitter stake triggers SEC probe - WSJ
RE
05/19ELON MUSK : Musk says 'Tesla is on my mind 24/7' amid concerns about Twitter distraction
RE
05/10ELON MUSK : Elon Musk says Tesla open to buying a mining company
RE
05/17ELON MUSK : Prominent hedge funds invested in Twitter before Musk unveiled plans
RE
05/17JPMorgan shareholders vote disapproval of CEO Dimon's special payout
RE
05/23HOCK TAN : Chipmaker Broadcom in talks to acquire VMware for $60 billion -sources
RE
More news


© 2022 People and Ownership :   
Andrew C. von Eschenbach : Connections